PAR 0.00% 26.5¢ paradigm biopharmaceuticals limited..

Ann: Paradigm Reports Australian Patent Acceptance, page-15

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 73 Posts.
    lightbulb Created with Sketch. 17
    Not much has changed as a patent was inevitable. As a holder it's a nice little kick up but the product needs to be proven successful in the real world. I have had consultations with numerous sports physicians for arthritis in my knees - I was considered a good candidate and it didn't do a thing for me 5 months ago. Pentosan has been around for many years and there's a good reason the major pharmas haven't pursued with it. Having said that I'm happy to ride it out with a small parcel. Hopefully it can help some people in some form...disappointed that wasn't the case for me after getting my hopes up
    Last edited by Hammer24: 30/06/22
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.